E.l.f. Beauty stock plunges 29% on weak guidance, tariff impact
News Brief: E.l.f. Beauty Earnings Report Summary E.l.f. Beauty reported mixed Q2 fiscal results, missing revenue estimates but beating on […]
CNBC, News
News
ABC, News
Company says group ‘created unnecessary fear’ over recycling plant
News Brief Summary RePoly is appealing the rejection of its planned plastic recycling plant in Moss Vale, NSW, accusing a
ABC, News
Secret report challenges government claim WA gas will help world decarbonise
News Brief Summary A confidential report commissioned by the Western Australian (WA) government, conducted by Deloitte for $402,000, challenges the
ABC, News
China lifts some tariffs on US farm goods but soybeans remain costly
News Brief Summary China has suspended some retaliatory tariffs on US agricultural imports but will maintain a 13% tariff on
ABC, News
Who could benefit most from Labor’s proposed Solar Sharer scheme?
News Brief: Labor’s Solar Sharer Scheme Summary The Australian federal government is proposing a “Solar Sharer” scheme, offering free electricity
ABC, News
China lifts some tariffs on US farm goods but soybeans remain costly
News Brief Summary China has suspended some retaliatory tariffs on US agricultural imports but will maintain tariffs on key goods
ABC, News
Who could benefit most from Labor’s proposed Solar Sharer scheme?
News Brief: Labor’s Solar Sharer Scheme Summary The Australian federal government proposes a “Solar Sharer” scheme offering free electricity for
ABC, News
Who could benefit most from Labor’s proposed Solar Sharer scheme?
News Brief: Labor’s Solar Sharer Scheme Summary The Australian federal government is proposing a “Solar Sharer” scheme that would offer
CNBC, News
Comcast warns of pressures in broadband, its cornerstone unit
News Brief: Comcast Q3 2024 Earnings Summary Comcast reported Q3 earnings that beat Wall Street estimates for revenue and profit.
CNBC, News
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit
News Brief Summary Merck reported strong Q3 earnings, beating estimates due to high demand for its cancer drug Keytruda. The